Carol Cheung

Title: **The Innovative Contributions of Carol Cheung in Glaucoma Screening Technologies**

Introduction

Carol Cheung, a pioneering inventor based in Singapore, has made significant strides in the development of advanced medical technologies for glaucoma screening. With a total of two patents to her name, her work focuses on integrating genomic data with ocular imaging to enhance the accuracy of glaucoma risk assessments.

Latest Patents

Cheung's latest patents revolve around the innovative concept of obtaining data for automatic glaucoma screening and developing screening and diagnostic techniques and systems utilizing that data. Her system employs non-stereo fundus images to derive a multitude of glaucoma indicators. Additionally, it incorporates genetic marker data associated with one or more genes and SNPs related to glaucoma. By feeding both glaucoma indicators and genetic marker data into an adaptive model, her results provide a more comprehensive understanding of glaucoma risk than either data set alone. The two-stage adaptive model further enhances this analysis, combining individual genetic indicators with genome data to produce outputs that indicate the potential risk of glaucoma in subjects. Notably, texture analysis is performed on fundus images to ensure their quality before they are analyzed for glaucoma indicators. Cheung's approach also includes innovative methods for estimating the positions of the optic cup and disc, underscoring her commitment to improving glaucoma diagnostic techniques.

Career Highlights

Throughout her career, Carol Cheung has collaborated with esteemed organizations such as the Agency for Science, Technology and Research and Singapore Health Services Pte Ltd. Her roles in these institutions have fortified her expertise and bolstered her contributions towards the field of ophthalmology. Cheung's work not only highlights her inventive spirit but also showcases her dedication to enhancing healthcare technology.

Collaborations

Collaboration has been a cornerstone of Cheung's innovative journey. She has worked alongside notable colleagues, including Jiang Liu and Zhuo Zhang, who have contributed to her research and development initiatives. These collaborations have paved the way for transformative advancements in the screening of glaucoma, benefiting patients and healthcare providers alike.

Conclusion

Carol Cheung stands out as an influential inventor whose work in glaucoma screening technologies reflects a blend of innovation and scientific rigor. Her innovative patents and collaborative efforts signify a vital contribution to the field of medical diagnostics, promising to enhance the early detection and management of glaucoma. As she continues her work, her impact in this critical area of healthcare is poised to grow even more significant.